Assignee
RESTEM LLC
US·3 granted patents·3 pending applications·0 citations·filing 2015–2024
Top patents by PatentIndex Score
6 records- 0166US11446329B2Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBSRESTEM LLC·Filed 2018·Granted Sep 20, 2022·0 cites·17 claims
- 0262US2023018682A1Methods and compositions of natural killer cell adoptive transfer therapyRESTEM LLC·Filed 2022·Application pending·0 cites
- 0359US12460179B2Lyophilized compositions containing umbilical cord lining stem cells conditioned mediumRESTEM LLC·Filed 2021·Granted Nov 4, 2025·0 cites·6 claims
- 0459US2025230404A1Method of using factor rich product from umbilical cord mesenchymal stem cells to increase collagen and elastin in human skinRESTEM LLC·Filed 2024·Application pending·0 cites
- 0553US2021355437A1Factor rich product from umbilical cord mesenchymal stem cellsRESTEM LLC·Filed 2021·Application pending·0 cites
- 0649US10760054B2Natural killer cells and methods for enhancing viability, proliferation and cytotoxicity of same following cryopreservationRESTEM LLC·Filed 2015·Granted Sep 1, 2020·0 cites·16 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →